» Articles » PMID: 23651439

Assessing Willingness to Test for HIV Among Men Who Have Sex with Men Using Conjoint Analysis, Evidence for Uptake of the FDA-approved At-home HIV Test

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2013 May 9
PMID 23651439
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Men who have sex with men (MSM) in the USA, represent a vulnerable population with lower rates of HIV testing. There are various specific attributes of HIV testing that may impact willingness to test (WTT) for HIV. Identifying specific attributes influencing patients' decisions around WTT for HIV is critical to ensure improved HIV testing uptake. This study examined WTT for HIV by using conjoint analysis, an innovative method for systematically estimating consumer preferences across discrete attributes. WTT for HIV was assessed across eight hypothetical HIV testing scenarios varying across seven dichotomous attributes: location (home vs. clinic), price (free vs. $50), sample collection (finger prick vs. blood), timeliness of results (immediate vs. 1-2 weeks), privacy (anonymous vs. confidential), results given (by phone vs. in-person), and type of counseling (brochure vs. in-person). Seventy-five MSM were recruited from a community-based organization providing HIV testing services in Los Angeles to participate in conjoint analysis. WTT for HIV score was based on a 100-point scale. Scores ranged from 32.2 to 80.3 for eight hypothetical HIV testing scenarios. Price of HIV testing (free vs. $50) had the highest impact on WTT (impact score = 31.4, SD = 29.2, p<0.0001), followed by timeliness of results (immediate vs. 1-2 weeks) (impact score = 13.9, SD = 19.9, p≤0.0001) and testing location (home vs. clinic) (impact score = 10.3, SD = 22.8, p=0.0002). Impacts of other HIV testing attributes were not significant. Conjoint analysis method enabled direct assessment of HIV testing preferences and identified specific attributes that significantly impact WTT for HIV among MSM. This method provided empirical evidence to support the potential uptake of the newly FDA-approved over-the-counter HIV home test kit with immediate results, with cautionary note on the cost of the kit.

Citing Articles

Preferences and Acceptability of Testing for Sexually Transmitted Infections in an HIV Pre-Exposure Prophylaxis Clinic in Hanoi, Vietnam.

Bui H, Adamson P, Nguyen T, Dau N, Nguyen K, Pham L Sex Transm Dis. 2024; 52(4):242-247.

PMID: 39625476 PMC: 11888897. DOI: 10.1097/OLQ.0000000000002109.


Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study.

Coursey K, Muralidhar K, Srinivas V, Jaykrishna P, Begum F, Ningaiah N BMC Public Health. 2024; 24(1):2139.

PMID: 39112938 PMC: 11304586. DOI: 10.1186/s12889-024-19485-8.


Is there a "price that's right" for at-home COVID tests?.

Kirby R, Maimaran M, Palamountain K PLoS One. 2023; 18(3):e0282043.

PMID: 36913352 PMC: 10010528. DOI: 10.1371/journal.pone.0282043.


Use of Stated Preference Methods in HIV Treatment and Prevention Research in the United States: A Systematic Review.

Rodriguez C, Mitchell J AIDS Behav. 2023; 27(7):2328-2359.

PMID: 36809490 DOI: 10.1007/s10461-022-03962-5.


Mental health service preferences of patients and providers: a scoping review of conjoint analysis and discrete choice experiments from global public health literature over the last 20 years (1999-2019).

Larsen A, Tele A, Kumar M BMC Health Serv Res. 2021; 21(1):589.

PMID: 34144685 PMC: 8214295. DOI: 10.1186/s12913-021-06499-w.


References
1.
Lee S, Newman P, Comulada W, Cunningham W, Duan N . Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences. Int J STD AIDS. 2012; 23(4):235-41. PMC: 3372064. DOI: 10.1258/ijsa.2011.011189. View

2.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

3.
Chen M, Bilardi J, Lee D, Cummings R, Bush M, Fairley C . Australian men who have sex with men prefer rapid oral HIV testing over conventional blood testing for HIV. Int J STD AIDS. 2010; 21(6):428-30. DOI: 10.1258/ijsa.2010.009552. View

4.
Cohen M, Gay C . Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010; 50 Suppl 3:S85-95. PMC: 4147719. DOI: 10.1086/651478. View

5.
Chou R, Huffman L, Fu R, Smits A, Korthuis P . Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005; 143(1):55-73. DOI: 10.7326/0003-4819-143-1-200507050-00010. View